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Introduction
 Gynecologic cancer has a significant effect on patients 
as its diagnosis and treatment are difficult and intensive. 
The disease leads to a change in the patient’s lifestyle. 
Understanding the nature of cancer and the development 
of new diagnostic and treatment facilities for the extension 
of patient survival has drawn attention to improving the 
quality of life (Akkuzu, 2013). 
 Quality of life is a multidimensional concept that 
describes the physical, mental and social wellbeing status. 
It includes daily living activities together with symptoms 
of disease and treatment with its physical dimension and 
cancer patients including gynecological cancer are prone 
to significant problems that negatively affect the quality 
of life (Ell et al., 2008; Luckett et al., 2010; Fader et al., 
2011; Van Cleave et al., 2011; 2012).
 Functional status is a multi-dimensional concept 
associated with the individual’s biological status, 
disease and symptoms. Acute and chronic diseases, old 
age, disability, and drug use that disrupts functioning 
worsens the functional health status of the individuals 
and negatively affects their quality of life (Van Cleave 
et al., 2012). Functional status consists of the individual 
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Abstract
 Background: Functional status is the ability to perform daily activities. Little is known about quality of life 
and health status of gynaecological cancer  patients. The present study therefore aimed to evaluate the functional 
status of women receiving treatment for gynecological oncological disease while not hospitalised. Materials and 
Methods: This descriptive study covered 42 patients monitored by the Gynecological Oncology Unit in 2011. 
Data were collected using the Functional Living Index-Cancer and analysed with the chi square test, independent 
samples t-test, Mann-Whitney U test, one-way ANOVA test and the Kruskal-Wallis H test. Results: Of the 42 
cases, 66.7% had been diagnosed within the previous year and 90.5% were undergoing chemotherapy. The most 
severe symptoms experienced were pain (35.7%), fatigue-weakness (40.5%) and nausea and vomiting (56.5%). 
Daily activities where the most difficulty was experienced were housework (28.6%), average pace walking 
(31.0%), carrying more than 5 kg (28.6%). The mean Functional Living Index score was quite high (103.5±24.1). 
FLIC-C scale scores did not vary with the educational status, diagnosis duration, and family history of cancer 
(p>0.05). Conclusions: Evaluation of the functional status of gynecological cancer patients and how they cope 
with problems should indicate to healthcare professionals what help can be given to maintain quality of life. 
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performing normal daily activities, meeting his/her basic 
requirements, performing the daily roles and maintaining 
his/her health and wellbeing. It is associated with the 
medical, emotional and cognitive health of the individual. 
The presence of disease prevents the individual from 
fulfilling daily responsibilities and this causes emotional 
problems (Ell et al., 2008; Luckett et al., 2010; Fader et al., 
20011;Van Cleave et al., 2011; 2012). Loss of functional 
status is associated with shorter survival, compromised 
quality of life, depression, and severe economical burden 
for patients and their caregivers (Van Cleave et al., 
2011; Sharma et al., 2012). After a gynecological cancer 
diagnosis, there is a possibility of physical capacity 
limitations, changes in sexual function, changes in roles 
in the family, at work and socially, and recurrence of 
the disease in the patients depending on the disease and 
treatment options (Akkuzu, 2013). Also the gynecologyc 
cancers was seen mostly in elderly women and first step of 
treatment is surgery (Van Cleave et al., 2012). Functional 
status of older adults serves as an important healthcare 
indicator and research outcome (Van Cleave et al., 2011). 
Studies have revealed the effects of surgery, radiation and 
chemotherapy on the quality of life in gynecologic cancer 
(Akuzu, 2012; Gogoi, 2012; Van Cleave et al., 2012). 
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 Although there are prospective studies on the quality of 
life in the first two-year period after initiation of treatment 
in patients with gynecological cancer, very little is known 
about long-term (≥5 years) quality of life and health. There 
are also very few studies examining the quality of life of 
individuals diagnosed with and treated for gynecologic 
cancer in developing countries (Chalas, 2013) also in 
Turkey.
 This study was planned to evaluate the functional 
status of individuals receiving treatment for gynecological 
oncology disease during the phases not requiring 
hospitalization.
Materials and Methods
Design, research setting and sampling 
 This was a descriptive study. The study universe 
consisted of the patients followed-up at Ankara University 
Department of Obstetrics and Gynecology’s Gynecologic 
Oncology Clinic in the year prior to the study date. The 
study aimed to reachall the study universe by not selecting 
a sample. We found that 92 women were treated in the 
clinic in 2011. Of these females, all subjects over 18 years 
of age with outpatient follow-up during the study and who 
were diagnosed at least 3 months previously were included 
in the study (n=42, 45.6%). 
Data collection and analysis 
 The data were completed at the clinic by the 
investigatorsusing the FLIC Scale (Functional Living 
Index-Cancer) and the data collection form via face-to-
face interviews with the patient.
Functional life scale-cancer (FLIC-Cancer) 
 This scale was developed by Schipper et al. (1984) in 
order to assess the functional status and quality of life in 
individuals with cancer, and its validity and reliability in 
Turkey werestudied by Bektas and Akdemir (2006). The 
scale consisting of 22 questions was prepared according 
to the 7-item Likert Scale. Options consisted of seven 
categories listed from positive to negative. Functional 
Living Scale options were scored as 7 to 1 for negative 
questions and 1 to 7 for positive questions.The scale results 
were found by adding the point value of each question. 
The Functional Life Index has 5 subtitles: Physical 
Functions, Psychological Functions, General Wellbeing 
(Cancer-related Challenges), Social Functions, and 
Gastrointestinal Symptoms (Nausea, etc.). The maximum 
score on the scale is 154 and the minimum score 22, with 
high scores indicating good functional status and quality 
of life (Schipper et al., 1984; Bektas and Akdemir, 2006; 
Bektas and Akdemir, 2008). The subscale Cronbach alpha 
values in this study were 0.910 (Physical Functions), 0.845 
(Psychological Functions), 0.866 (General Well-Being), 
0.924 (Social Functions) and 0.712 (Gastrointestinal 
Symptoms) (Table 5).
 Basic descriptive statistics (mean, SD, frequency), 
percentage chi square test, Independent-Samples t-test, 
Mann-Whitney U-test, One-Way ANOVA test and 
Kruskal-Wallis H test were used for statistical analyses. A 
p value under 0.05 was considered statistically significant.
Ethical dimensions 
 After receiving the consent of the Ankara University 
Faculty of Medicine Cebeci Hospital Chief of Staff and the 
Department of Obstetrics and Gynecology and Oncology 
Department for the study, permission was obtained 
from the Ankara University Faculty of Medicine Ethics 
Committee. All patients in the study group were explained 
the aim of the study, emphasizing that participation was 
voluntary and the information would be kept confidential. 
Table 1. Sociodemographic and Gynecologic Oncologic 
Disease Characteristics of the Patients
  Number % 
1a. Sociodemographic characteristics n=42
Mean age (years)  
[Mean: 54.90±10.34 (min=30, max=80)]  
 ≤54 21  50.0 
 >54 21  50.0 
Educational level  
 Illiterate 13  31.0 
 Primary school 19  45.2 
 High school+University 10  23.8 
Marital Status  
 Married 35  83.3 
 Widow 7  16.7 
Marriage age (years)  
[Mean 31.90±12.20 (min=9, max=59)]  
 <32 17  40.5 
 ≥32 25  54.7 
 Does not know 2  4.8 
Financial Status  
 Income more than expenses 3  7.1 
 Income equivalent to expenses 32  76.2 
 Income less than expenses 7  16.7 
1b. Gynecologic oncological disease characteristics n=42  
Diagnosis  
 Ovarian cancer 36  83.5 
 Endometrial cancer 5  11.9 
 Krukenberg tumor (ovary metastasis) 1  2.4 
 Bladder tumor (ovary metastasis) 1  2.4 
Cancer Stage  
 Stage 1 1  2.4 
 Stage 2 3  7.1 
 Stage 3 23  54.8 
 Stage 4 9  21.4 
 Not staged 8  14.3 
Diagnosis time (year)  
[Mean 1.74±1.41 (min=1, max=6)]  
 One 28  66.7 
 Two+ 14  33.7 
Current treatment  
 Chemotherapy 38  90.5 
 Surgical treatment 3  7.1 
 Radiotherapy 1  2.4 
Previously administered treatment  
 Chemotherapy 10  23.9 
 Surgical treatment 29  69.0 
 Not treated 4  7.1 
Receiving social support during disease process  
 Yes 41  97.6 
 No 1  2.4 
The person providing social support*  
 Husband 33  81.3 
 Mother 5  12.2 
 Father 7  17.1 
 Siblings 23  56.1 
 Children 31  75.6 
 Other relatives 11  26.8 
 Friend 16  39.0 
 Neighbors 11  26.8 
*More than one answer given
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They were also ensured that their answers to the 
questionnaire would not affect their treatment.
 “Human beings” were an element of the study, which 
was therefore conducted in accordance with the principles 
of the 2008 Helsinki Declaration.
Results 
 The mean age of the women participating in the 
study was 54.90±10.34 years, 45.5% were primary 
school graduates and 31% were illiterate. 83.3% of the 
patients were married and the mean age of marriage was 
31.90±20.12 years with 40.5% getting married before the 
age of 32. The income of 76.2% of women was equal to 
their expenses, while 16.7% had less income than their 
expenses (Table 1a). 83.5% of women included in this 
study had ovarian cancer and the cancer was Stage 3 
and above in of 90.5%. 66.7% of the patients had been 
diagnosed with cancer within the last year. The treatment 
currently administered was chemotherapy in 90.5% and 
the previous treatment was surgical in 69%. Social support 
from one or more persons during cancer treatment had 
been received by 97.6% of the participants with 81.3% 
from their husbands, 75.6% from their children, and 
56.1% from their siblings (Table 1b).The mean number 
of births was 4.67±2.65. A history of yellow-green, 
whitish or pink-red vaginal discharge was present in 
21.4%. The women did not report a history of sexually 
transmitted infections in themselves or their partners. 
21.4% of the participants had received HRT previously 
and 40.5% had a family history of cancer. Of the patients 
with a family history of cancer, a cancer diagnosis was 
present in the father in 29.4%, the mother in 23.5% and 
the sister in 23.5% as reported by the patient. The types 
of cancer seen most commonly in the family were lung 
cancer (17.7%), breast cancer (7.17) and stomach cancer 
(11.6%) in order of frequency. A large number of patients 
had experienced fatigue (40.5%), pain (35.7%), and 
nausea and vomiting (26.2%) in the last two weeks. Of 
these problems, the most frequently used interventions 
were medical treatment for symptoms of pain (64.2%), 
and nausea and vomiting (59.5%), and rest for fatigue 
(45.2%) (Table 2). When the status of performing daily 
living activities was examined, the rates of being able 
to do the functions that required more energy was low 
(doing housework 28.6%, walking at moderate speed 
31.0%, carrying more than 5 kg 28.6%). As seen in the 
Table, 11.9-14.5% of the patients reported not being able 
to do these functions (Table 3). The Functional Life Scale 
total mean score was 103.45±24.08 (min: 53.00-max: 
152.00) and the subscale scores were Physical Functions 
37.83±11.69, Psychological Functions 24.7±11.8, General 
Wellbeing; 12.40±5.05, Social Functions 8.50±3.57 and 
Gastrointestinal Symptoms 8.14±3.41 (Table 4).
 The Functional Living Scale mean scores of the 
patients were evaluated according to the age group, 
education, years of diagnosis, and presence of cancer in the 
family history, and no statistically significant difference 
was found between the mean scores as regards these 
factors (Table 5, p>0.05).
Discussion
There are only a few studies in the literature examining 
the quality of life in patients with gynecologic cancers 
compared to cancer in general globally as well as in 
Turkey. An important characteristic of our study is that it 
is the first to use the FLIC scale in gynecologic oncology 
patients in Turkey. 
83.5% of the women included in this study had ovarian 
cancer and the cancer was Stage 3 and above in 90.5%. 
The cancer diagnosis had been made in the last year in 
Table 2. The Problems Experienced During Last two 
Weeks and Actions Taken for These Problems
Problem n=42 Number    %
Fatigue Little 7  16.7 
 Moderate 18  42.9 
 A lot 17  40.5 
Action for fatigue Medical treatment 7  16.7 
 Resting 19  45.2 
 None 16  38.1 
Pain Little 13  31.0 
 Moderate 14  33.3 
 A lot 15  35.7 
Action for pain Medical treatment 27  64.2 
 Non-pharmacological implementation 2  4.8 
 None 13  31.0 
Nausea and vomiting  
 Little 20  47.6 
 Moderate 11  26.2 
 A lot 11  26.2 
Action for nausea and vomiting  
 Medical treatment 25  59.5 
 None 17  40.5 
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Table 3. The distribution of the effect of the Problems Related to the disease on Daily Living Activities
Daily Living Activities (n:42) I can do it easily I can do it with difficulty I can do it with help I cannot do it
 Number   % Number   % Number   % Number   %
 Getting dressed- undressed 25  59.5  15  35.7  2  4.8  - -
 Taking a bath 27  64.3  13  31.0  2  4.8  - -
 Eating 27  64.3  13  31.0  2  4.8  - -
 Doing housework 12  28.6  21  50.0  4  9.5  5  11.9 
 Going upstairs 15  35.7  21  50.0  6  14.3  - -
 Going downstairs 19  45.2  17  40.5  6  14.3  - -
 Walking at moderate speed 13  31.0  19  45.2  5  11.9  5  11.9 
 Walking slowly 24  57.1  12  28.6  6  14.3  - -
 Standing easily 24  57.1  14  33.3  3  7.1  1  2.4 
 Speaking 35  71.4  10  23.8  - - - -
 Using the toilette 30  71.4  10  23.8  1  4.8  - -
 Lifting-carrying things heavier than 5 kg 12  28.6  21  50.0  3  7.1  6  14.3 
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66.7% of the patients and the current form of treatment 
was chemotherapy in 90.5%. The social support of our 
patients seemed to be good in general: 81.3% received 
support from their husbands, 75.6% from their children, 
and 56.1% from their siblings (Table 1b). Social support 
is an important resource that can help cancer patients cope 
with their fear and doubts (Arriba et al., 2010).
Eylen’s study (2002) found that the subjects received 
social support from one or more persons during cancer 
treatment. Similar to the results of that study, women 
receiving gynecological cancer treatment expressed 
receiving support mostly from their husbands and children 
in Akkuzu’s (2012) study. Ozkan and Ogce (2008) was 
found in their study on Turkish women with breast cancer 
who mostly under chemotherapy the main conclusion 
that can be drawn from these data is that friend support 
significantly affects both general functional state and 
social and community activities as it is revealed by the 
examination of the effect of social support on functional 
state. Also, general social support scores significantly 
improve occupational activities.
Reis (2006) found that patients with higher levels of 
education and with better husband and social support 
systems coped more easily with the side effects of 
treatment in a study conducted with gynecological cancer 
patients. Reis et al. (2010) found a fairly high level of 
support from family, parents and friends and emphasized 
that this support contributed to the development of the 
patients’ social well-being as a feature of life in Turkish 
society in another study with gynecologic oncology 
patients. A statistically significant difference was found 
between the mean scores of the social function subscales 
according to whether the patient had a family history of 
cancer (p<0.05). According to this results, the individuals 
experiencing similar problems in our society may be 
considered to be more effective in understanding and 
supporting each other. We found that the patients had 
experienced a lot of fatigue, pain, and nausea and vomiting 
in the last two weeks, and the most common interve]ntion 
used was medical treatment for the symptoms of pain and 
nausea, and resting for fatigue (Table 3).
Fatigue, pain and nausea were the most common 
symptoms under chemotherapy in women diagnosed with 
gynecologic cancer in Akkuzu’s study (2012) as well. We 
found that the patients’ ability to perform the functions that 
required more energy was low. Similarly, 81.6% of women 
with a diagnosis of ovarian cancer, with the majority 
were receiving chemotherapy, expressed having difficulty 
in doing housework due to fatigue (Akkuzu, 2012). 
Accorgding to study Ogce and Ozkan (2008) women’s 
functional status with breast cancer according to the cancer 
Table 4. The Distribution of Subscale Scores of the Functional Life Scale*
 Subscale title Item number Min Max Cronbach’s alpha Mean SD
 Physical Functions 9  17  60  0.910  37.83  11.6 
 Psychological Functions 6  10  38  0.845  24.07  8.11 
 General Wellbeing (Difficulties Related to Cancer)” 3  4  19  0.866  12.40  5.05 
 Social Functions 2  2  14  0.924  8.50  3.57 
 Gastrointestinal Symptoms (Nausea etc.)” 2  2  14  0.712  8.14  3.41
* Min: 53.00-Max: 152.00, mean 103.45±24.08
Table 5. Functional Life Scale Subscale Mean Scores, SD and Statistical Significance Results of the Patients 
According to Some Chosen Variables
Variable  Functional Life Scale subscale mean score±SD
 Physical Psychological  General Social Gastrointestinal
 Functions Functions Wellbeing Functions Symptoms
Age ≤ 54 39.90±11.37 23.52±7.94 13.66±4.80 8.66±3.66 9.09±3.36
 >54 35.76±11.92 24.61±8.44 11.14±5.08 8.33±3.56 7.19±3.26
  Z=-1.032, p=0.302 Z=-0.403, p=0.687 Z=-1.528, p=0.127 Z=-0.274, p=0.784 Z=-0.825, p=0.068
Education Illiterate 37.38±11.85 25.23±8.58 12.76±5.32 8.84±3.21 7.92±3.61
 Primary school 36.36±12.60 23.42±8.46 11.52±5.16 7.94±3.77 7.94±3.51
 High school 41.20±11.69 23.80±7.43 13.60±4.64 9.10±3.84 8.80±3.19
 +University X2=1.063, p=0.588 X2=0.327, p=0.849 X2=1.134, p=0.540 X2=0.741, p=0.690 F=0.235, p=0.793
Years of diagnosis One 39.14±12.23 24.75±8.20 12.89±5.10 8.85±3.59 8.21±2.93
 Two + 35.21±10.46 22.71±8.05 11.42±4.97 7.78±3.55 8.00±4.33
  Z=-1.042, p=0.298 Z=-0.575, p=0.566 Z=-0.750, p=0.453 Z=-0.997, p=0.310 Z=-0.051, p=0.957
Family history of cancer Yes 38.47±11.69 23.17±7.66 12.82±5.24 6.94±3.61 8.47±3.44
 No 37.40±11.91 24.68±8.50 12.12±5.00 9.50±3.20 7.92±3.3
  Z=-0.218, p=0.827 Z=-0.398, p=0.691 Z=-0.502, p=0.616 Z=-2.301, p=0.021** Z=-0.491, p=0.624
Table 6. Functional Life Scale Subscale Mean Scores, 
SD and Statistical Significance Results of the Patients 
According to Some Chosen Variables
Variable Functional Life Scale
 n Mean SD Statistics
Age    
 ≤ 54 21  94.19  25.12  Z= -0.805
 >54 21  86.71  27.76  p=0.421
Education    
 Illiterate 13  91.61  27.06  X²=0.578
 Primary school 19  87.15  29.21  p=0.749
 High school +University 10  95.20  21.17  
Years of diagnosis    
 One 28  93.32  26.30  Z= -0.934
 Two + 14  64.71  26.69  p=0.350
Family history of cancer    
 Yes 17  89.52  26.30  Z= -0.179
 No 25  91.08  27.03  p=0.858
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functional status inventory the after chemotherapy scores 
were lower and significantly different for household and 
family activities similarly in the study.
The Functional Life Scale scores of the patients in the 
study were Physical Functions 37.83±11.69, Psychological 
Functions 24.7±11.8, General Wellbeing 12:40±5:05, 
Social Functions; 8:50±3:57 and Gastrointestinal 
Symptoms 8.14±3.41 (Table 5). The study of Akkuzu 
(2012) using the EORTC-QLQ-C30 Quality of Life index 
in women whose mean diagnosis duration was 2 years and 
received chemotherapy and of which 7.3% had ovarian 
cancer found disturbed physical, emotional, social and 
cognitive function. The general score in that study was 
higher than the general wellbeing score in this study. 
This may be due to the presence of more advanced stage 
gynecologic cancer in the sample group in our study. As 
seen in table 7, the functional life scale mean score of 
the group with a diagnosis duration of 2 years and above 
(64.71) was lower than the newly diagnosed group (93.3). 
83.5% of the women in this study were diagnosed 
with ovarian cancer, and 76.2% were being treated in 
stage III and IV. Arriba et al. (2010) reported the quality 
of life of women with ovarian cancer in stage I and II to 
be statistically significantly higher than in stage III and IV.
The Functional Life Scale subscale scores were 
evaluated according to the mean age group, educational 
status and diagnosis duration of the patients and the 
difference between the mean scores were not statistically 
significant (p>0.05). Educational status was also a variable 
that did not affect the quality of life in Akkuzu’ s study 
(2012). The quality of life appears to be more associated 
with the intensity of symptoms experienced and the 
presence of psychosocial support. However, although the 
psychosocial stress was found to be moderately high in 
another study conducted in patients with gynecological 
cancer, the quality of life was found to be high with the 
FLIC scale (Pilkington and Mitchell, 2004).
The implementation of initiatives to improve the 
quality of life of individuals with gynecologic cancer 
during the process of diagnosis and treatment is important. 
This study may guide health care staff in the evaluation 
of patients’ functional status and when helping patients to 
cope with the physical, psychological and social problems.
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